# Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma

> **NCT01758458** · PHASE1,PHASE2 · TERMINATED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 4 (actual)

## Conditions studied

- Recurrent Merkel Cell Carcinoma
- Stage IV Merkel Cell Carcinoma

## Interventions

- **BIOLOGICAL:** Aldesleukin
- **OTHER:** Laboratory Biomarker Analysis
- **BIOLOGICAL:** MCPyV TAg-specific Polyclonal Autologous CD8-positive T Cells
- **RADIATION:** Radiation Therapy
- **BIOLOGICAL:** Recombinant Interferon Beta

## Key facts

- **NCT ID:** NCT01758458
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-02
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** A Phase I/II study (NCT01758458) is now recruiting
- **Last updated:** 2017-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01758458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01758458, "Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01758458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*